Form 8-K - Current report:
SEC Accession No. 0001140361-23-054994
Filing Date
2023-11-28
Accepted
2023-11-28 16:01:35
Documents
13
Period of Report
2023-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20015457x1_8k.htm   iXBRL 8-K 34107
2 EXHIBIT 2.1 ny20015457x1_ex2-1.htm EX-2.1 29925
  Complete submission text file 0001140361-23-054994.txt   204412

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usnu-20231128.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usnu-20231128_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usnu-20231128_pre.xml EX-101.PRE 16042
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20015457x1_8k_htm.xml XML 3774
Mailing Address 2400 RESEARCH BLVD SUITE 325 ROCKVILLE MD 20850
Business Address 2400 RESEARCH BLVD SUITE 325 ROCKVILLE MD 20850 3012088998
U.S. NeuroSurgical Holdings, Inc. (Filer) CIK: 0001089815 (see all company filings)

EIN.: 521842411 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26575 | Film No.: 231446297
SIC: 8093 Services-Specialty Outpatient Facilities, NEC